Join
Live feed
·
INSIDERFilingvia Quantisnow
Pulse Biosciences Inc logo

Chief Commercial Officer Danahy Kevin Patrick converted options into 650 shares, increasing direct ownership by 2% to 36,537 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
PLSE· Pulse Biosciences Inc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PLSE (Pulse Biosciences Inc) and more on Quantisnow.